Asbestos-related diseases
Lung and pleural disorders from inhaled asbestos fibres.
Wikipedia / Wikimedia Commons
Asbestos-related diseases are disorders of the lung and pleura caused by the inhalation of asbestos fibres. They include non-malignant conditions such as asbestosis, diffuse pleural thickening, pleural plaques, pleural effusion, and rounded atelectasis, as well as malignancies like lung cancer and malignant mesothelioma. These diseases primarily affect individuals with high occupational exposure, but para-occupational and environmental exposures also occur, particularly from asbestos remaining in older buildings.
- field
- Occupational and environmental medicine
- known_for
- Causing pulmonary fibrosis, pleural abnormalities, and malignancies after asbestos inhalation
- prevalence_among_workers
- Up to 58% of asbestos-exposed workers develop pleural plaques
- latency_for_pleural_plaques
- 20 to 40 years after first exposure
- latency_for_asbestosis
- 15 or more years from initial exposure
Lore & Background
Asbestos-related diseases arise when inhaled fibres enter the respiratory tract. Long thin fibres, especially amphibole types, are retained in the lungs for years, triggering inflammation and fibrosis. From the lungs, short fibres can migrate to pleural and peritoneal spaces. The pleura is more sensitive than lung tissue, so pleural diseases can result from lower doses than lung fibrosis.
Pleural plaques, the most common manifestation, affect up to 58% of exposed workers and appear 20–40 years after exposure. They are typically asymptomatic, though some studies report chest pain or restrictive impairment. Diffuse pleural thickening develops 20–40 years after exposure, often beginning with pleural effusion, and can cause breathlessness and reduced lung function. Benign asbestos pleural effusion is the earliest manifestation, usually within 10 years, and may resolve or progress to diffuse thickening. Rounded atelectasis is the least common benign pleural disease and may mimic a tumour on imaging.
Asbestosis is defined as diffuse interstitial pulmonary fibrosis from asbestos, initially affecting the lung bases after 15 or more years. It occurs after high-intensity exposure. Non-malignant pleural diseases are not pre-malignant, but they indicate increased risk for other asbestos-related diseases.
Reader's Guide
Asbestos-related diseases remain a significant public health concern due to the widespread historical use of asbestos in building materials. Even after restrictions, large quantities persist in older structures, and weathering or renovation can release fibres. The diseases have long latency periods—20 to 40 years for pleural plaques and diffuse thickening, and 15 or more years for asbestosis—meaning cases continue to emerge decades after exposure. Pleural plaques are the most common marker of past exposure, but they are not pre-malignant and are often not compensated. Diffuse pleural thickening, though rarer, has a greater impact on lung function and is compensable in many systems. The exact risks from environmental exposure are difficult to quantify, but the potential hazard from aging buildings underscores the need for careful management. Diagnosis relies on imaging, with CT scans more sensitive than X-rays. Treatment options for non-malignant diseases are limited, and new or severe pain requires investigation to exclude malignancy.
Did You Know?
- Pleural plaques affect up to 58% of asbestos-exposed workers and develop 20 to 40 years after first exposure.
- Benign asbestos pleural effusion is the earliest manifestation of disease, usually occurring within 10 years from exposure.
- Amphibole fibres are not cleared as effectively as serpentine fibres and accumulate more readily in the distal lung parenchyma.
- Diffuse pleural thickening accounts for 22% of all asbestos-related diseases according to the Australian SABRE scheme.
Frequently Asked Questions
What are Asbestos-related diseases?
They are lung and pleural disorders triggered by breathing in asbestos fibres over time. The category spans both non-cancerous conditions like asbestosis and pleural plaques, as well as cancers including lung cancer and malignant mesothelioma.
How long does it take for Asbestos-related diseases to show up?
The latency period is notably long, with pleural plaques typically appearing 20 to 40 years after the first exposure. Asbestosis generally requires at least 15 years from initial contact before symptoms emerge.
Who is most likely to develop Asbestos-related diseases?
Workers with heavy occupational exposure are the primary group affected, though family members and people living near asbestos-containing buildings can also be impacted. Among heavily exposed workers, up to 58% will develop pleural plaques.
What kinds of conditions are included under Asbestos-related diseases?
The umbrella term covers non-malignant issues such as asbestosis, diffuse pleural thickening, pleural plaques, pleural effusion, and rounded atelectasis. It also includes malignancies like lung cancer and malignant mesothelioma.
Why are Asbestos-related diseases a major topic in occupational medicine?
They sit at the intersection of occupational and environmental medicine because exposure can come from workplace settings, older buildings, or household contact. Their long latency and the wide range of outcomes—from benign plaques to fatal mesothelioma—make them a critical area of study and worker protection.
More in Occupational diseases 1-24
Spotted an error? Know more?
This is a living reference — every entry is fact-audited, and reader corrections feed straight into our audit queue. Suggest an edit · See this site's audit record